SPRC SciSparc Ltd.

Nasdaq scisparc.com


$ 2.35 $ 0.00 (0 %)    

Thursday, 20-Nov-2025 13:37:19 EST
QQQ $ 590.96 $ -20.88 (-3.41 %)
DIA $ 459.11 $ -7.57 (-1.62 %)
SPY $ 656.56 $ -16.34 (-2.43 %)
TLT $ 89.20 $ 0.21 (0.24 %)
GLD $ 373.42 $ -1.76 (-0.47 %)
$ 2.46
$ 2.50
$ 2.33 x 11
$ 2.41 x 25
-- - --
$ 1.75 - $ 37.59
15,920
na
82,783
$ 1.25
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), today announced that NeuroThera Labs Inc. (TSXV:NTLX) (&...

Core News & Articles

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech com...

Core News & Articles

N2OFF, Inc. (NASDAQ:NITO) ("N2OFF" and the "Company"), a cleantech company investing in solar energy assets bas...

Core News & Articles

SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusi...

Core News & Articles

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech com...

 scisparc-expands-biotech-ambitions-buys-stake-in-miza-iii-ventures

SciSparc traded higher after the company announced it had signed a definitive agreement to acquire a controlling stake in Miza ...

Core News & Articles

SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusi...

 scisparc-and-automax-call-off-merger

SciSparc ends merger with AutoMax, sets loan repayment terms, and refocuses on CNS drug development and innovation.

 scisparc-terminates-automax-merger-secures-625m-repayment-plan-with-structured-interest-terms

SciSparc Ltd. (NASDAQ:SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company fo...

Core News & Articles

Gainers SciSparc (NASDAQ: SPRC) shares increased by 28.2% to $5.68 during Monday's after-market session. The company's...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION